Details for Patent: 8,932,557
✉ Email this page to a colleague
Which drugs does patent 8,932,557 protect, and when does it expire?
Patent 8,932,557 protects TAUVID and is included in one NDA.
This patent has twenty-six patent family members in sixteen countries.
Summary for Patent: 8,932,557
| Title: | Imaging agents for detecting neurological dysfunction |
| Abstract: | Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled carbazoles and derivatives thereof and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease. |
| Inventor(s): | Chen; Gang (Redondo Beach, CA), Gangadharmath; Umesh B. (Los Angeles, CA), Kasi; Dhanalakshmi (Los Angeles, CA), Sinha; Anjana (San Diego, CA), Zhang; Wei (Los Angeles, CA), Chen; Kai (San Gabriel, CA), Mocharla; Vani P. (Los Angeles, CA) |
| Assignee: | Eli Lilly and Company (Indianapolis, IN) |
| Application Number: | 13/477,095 |
|
Patent Claim Types: see list of patent claims | Compound; Process; |
Drugs Protected by US Patent 8,932,557
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-001 | May 28, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-002 | May 28, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-003 | Jul 1, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,932,557
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012381042 | ⤷ Try a Trial | |||
| Canada | 2715390 | ⤷ Try a Trial | |||
| Canada | 2873963 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
